ArticleFrontiers in immunology2025

The impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of pegylated interferon-based therapy in patients with chronic hepatitis B.

Jiaxin Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.